An interventional study of Single vision contact lenses and Multifocal contact lenses in Myopia, sponsored by Visioneering Technologies, Inc. Active, not recruiting at 8 sites in 4 countries. Open to participants aged 7 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-22.
Sponsored by Visioneering Technologies, Inc · Not applicable, Interventional, and Treatment
This is a multi-center, randomized, double-masked clinical trial. All study devices are market approved/cleared in the localities where the study is conducted. Subjects will be randomly assigned to wear NaturalVue Sphere single vision contact lenses (SVCL) or NaturalVue Multifocal (NVMF) soft contact lenses for a total of three years.
984 studies on the registry are indexed under Myopia; 210 are open to participants now.
This study's planned enrollment of 144 is above the median of 80 across 783 interventional studies indexed under Myopia.
Browse Myopia studies →Visioneering Technologies, Inc is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Meet the following refractive criteria determined by cycloplegic autorefraction at Screening/Baseline:
Exclusion Criteria:
Contact lens with refractive correction, single vision optic
Device: Single vision contact lenses
Contact lens with refractive correction, multifocal optic
Device: Multifocal contact lenses
Wearing contact lenses during waking hours may alter the progression of myopia
Wearing contact lenses during waking hours may alter the progression of myopia
Change in Refractive Error relative to Baseline
Mean change in cycloplegic auto-refraction (D)
Time frame: Baseline, 12, 24, 36 months
Change in Axial Length
Mean change in Axial Length (mm)
Time frame: Baseline,12, 24, 36 months
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Visioneering Technologies, Inc